{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-098228","form_type":"8-K","ticker":"HIMS","cik":"0001773751","company_name":"Hims & Hers Health, Inc.","filed_at":"2024-09-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.480621+00:00","generated_at":"2026-05-31T05:55:54.039023+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Hims & Hers closes MedisourceRx acquisition; registers 976K shares for resale","bullets":["Acquisition of Seaview Enterprises LLC (MedisourceRx) closed on September 5, 2024.","976,341 shares of Class A common stock issued to Nivagen Pharmaceuticals as part of consideration.","Prospectus supplement filed on September 9, 2024 to register resale of those shares.","Purchase agreement was originally entered on July 5, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-098228","json":"https://secwatch.observer/filing/0001104659-24-098228.json","markdown":"https://secwatch.observer/filing/0001104659-24-098228.md","text":"https://secwatch.observer/filing/0001104659-24-098228.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1773751/000110465924098228/0001104659-24-098228-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1773751/000110465924098228/tm2422489d3_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T05:55:54.039023+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}